Although there appeared to be an increase in this metric with BLU2720 as well, the change from baseline was not as significant, reflecting the difference in potency of PIK3C2B inhibition between the 2 molecules ( Figure 3C ).
← all excerpts
Pharmacological PIK3C2B inhibition rescues XLMTM phenotype in mouse models and identifies molecular markers of disease.
1
—
—